Systems Biology Worldwide buys 4Pharma
Contract drug development group Systems Biology Worldwide (SBW) says the acquisition of Finnish data management specialist 4Pharma will facilitate its entry into the clinical trials sector.
Archives for March 25, 2009
GSK may move for Botox maker Allergan
The pharmaceutical rumour mill is still spinning with the latest speculation that UK drug major GSK is interested in Botox manufacturer Allergan causing the US firm’s share price to leap 13 per cent on the New York Stock Exchange.
AstraZeneca and BioDuro expand discovery contract
The Chinese unit of US contract drug discovery firm BioDuro says that AstraZeneca has expand its relationship with the firm to include the optimization of discovery research operations focused on drugs for respiratory and inflammatory disease.
Hospira’s “Project Fuel” will cut 1,400 jobs
US drug delivery specialist Hospira will reduce its workforce by around 10 per cent, or 1,400 employees, over the next 24 months as part of its $140m (€104m) a year “Project Fuel” cost cutting and efficiency drive.
Pharma mega mergers a boon for Patheon's restructuring service, says CEO
The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.